Relmada Therapeutics (RLMD) 8-K Other Events

Exhibit 99.1

Relmada Therapeutics, Inc

Proforma Balance sheet

June 30, 2019

	June 30, 2019
	Without Impact of Financing		Pro Forma Adjustments Resulting from Financings		Post Pro Forma Adjustments
Assets:
Current	$	9,984,381	$	1,275,750	$	11,260,131
Non-current	$	235,352			$	235,352
Total Assets	$	10,219,733	$	1,275,750	$	11,495,483
Liabilities and stockholders’ equity:
Current	$	2,606,418	$	-	$	2,606,418
Non-current	$	-	$	-	$	-
Total Liabilities	$	2,606,418	$	-	$	2,606,418
Stockholders’ equity	$	7,613,315	$	1,275,750	$	8,889,065
Total liabilites and stockholders’ equity	$	10,219,733	$	1,275,750	$	11,495,483

Note: Pro Forma adjustment is to account for the warrant exercise and Private Placement closed in September, 2019